Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire

BACKGROUND: Haemodialysis (HD) treatment causes a significant decrease in quality of life (QoL). When enrolled in a clinical trial, some patients are lost prior to follow-up because they die or they receive a kidney transplant. It is unclear how these patients are dealt with in the analysis of QoL d...

Descripción completa

Detalles Bibliográficos
Autores principales: Worboys, Hannah M, Cooper, Nicola J, Burton, James O, Young, Hannah M L, Waheed, Ghazala, Fotheringham, James, Gray, Laura J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681926/
https://www.ncbi.nlm.nih.gov/pubmed/35689670
http://dx.doi.org/10.1093/ndt/gfac170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681926/
https://www.ncbi.nlm.nih.gov/pubmed/35689670
http://dx.doi.org/10.1093/ndt/gfac170

Ejemplares similares